Nitric oxide, sepsis and liver metabolism.
Ceppi
E D
ED
School of Biological Sciences, University of Sussex, Brighton, U.K.
Smith
F S
FS
Titheradge
M A
MA
D000818:Animals; D016207:Cytokines / Q000494:pharmacology / Q000502:physiology; D005943:Gluconeogenesis; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008112:Liver Glycogen / Q000378:metabolism; D009569:Nitric Oxide / Q000502:physiology*; D011183:Postoperative Complications; D017382:Reactive Oxygen Species / Q000502:physiology; D018805:Sepsis / Q000453:epidemiology / Q000401:mortality / Q000503:physiopathology*; D012772:Shock, Septic / Q000503:physiopathology; D019323:omega-N-Methylarginine / Q000494:pharmacology
D016207:Cytokines; D008112:Liver Glycogen; D017382:Reactive Oxygen Species; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D005947:Glucose